Larson; Alyssa M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Larson; Alyssa M..The latest application filed is for "liquid protein formulations containing viscosity-lowering agents".

Company Profile

8.8.12

Larson; Alyssa M. - Dana Point CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Liquid Protein Formulations Containing Viscosity-Lowering Agents App 20210085792 - Larson; Alyssa M. ; et al.	2021-03-25
Liquid Protein Formulations Containing Organophosphates App 20210038718 - Larson; Alyssa M. ; et al.	2021-02-11
Liquid Protein Formulations Containing Ionic Liquids App 20210030877 - Larson; Alyssa M. ; et al.	2021-02-04
Liquid Protein Formulations Containing Thiamine Grant 10,849,977 - Larson , et al. December 1, 2	2020-12-01
Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (BIM) Grant 10,821,183 - Larson , et al. November 3, 2	2020-11-03
Liquid protein formulations containing thiamine pyrophosphate (TPP) Grant 10,821,184 - Larson , et al. November 3, 2	2020-11-03
Liquid protein formulations containing cimetidine Grant 10,646,571 - Larson , et al.	2020-05-12
Liquid pharmaceutical formulations for injection comprising yellow 5 or orange G and uses thereof Grant 10,179,172 - Larson , et al. Ja	2019-01-15
Polysaccharide And Nucleic Acid Formulations Containing Viscosity-lowering Agents App 20180228831 - LARSON; Alyssa M. ; et al.	2018-08-16
Liquid Protein Formulations Containing Cimetidine App 20180177875 - Larson; Alyssa M. ; et al.	2018-06-28
Liquid Protein Formulations Containing Thiamine App 20180177876 - Larson; Alyssa M. ; et al.	2018-06-28
Liquid Protein Formulations Containing Organophosphates App 20180153997 - Larson; Alyssa M. ; et al.	2018-06-07
Liquid Protein Formulations Containing Ionic Liquids App 20180085463 - Larson; Alyssa M. ; et al.	2018-03-29
Liquid pharmaceutical formulations for injection comprising procaine and uses thereof Grant 9,925,263 - Larson , et al. March 27, 2	2018-03-27
Liquid pharmaceutical formulations for injection comprising thiamine pyrophosphate 1-(3-aminopropyl)-2-methyl-1H-imidazole and uses thereof Grant 9,913,905 - Larson , et al. March 13, 2	2018-03-13
Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate and uses thereof Grant 9,833,513 - Larson , et al. December 5, 2	2017-12-05
Liquid Protein Formulations Containing Water Soluble Organic Dyes App 20150071920 - Larson; Alyssa M. ; et al.	2015-03-12
Liquid Protein Formulations Containing Viscosity-lowering Agents App 20150071925 - Larson; Alyssa M. ; et al.	2015-03-12
Liquid Protein Formulations Containing Organophosphates App 20150071921 - Larson; Alyssa M. ; et al.	2015-03-12
Liquid Protein Formulations Containing Ionic Liquids App 20150071922 - Larson; Alyssa M. ; et al.	2015-03-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.